Insider Trading & Ownership - Lundberg Sven Ante

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Lundberg Sven Ante
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-11-03
Purchase
2022-11-03
2:07 pm
Merus N.V.MRUSLundberg Sven Ante
President, CEO & PFO
14,706$14.38$211,43178,071
(Indirect
Direct)
View
2022-08-22
Purchase
2022-08-23
4:09 pm
Merus N.V.MRUSLundberg Sven Ante
President, CEO & PFO
5,826$22.92$133,55825,870
(Direct)
View
2022-08-19
Purchase
2022-08-22
3:02 pm
Merus N.V.MRUSLundberg Sven Ante
President, CEO & PFO
704$22.99$16,18720,044
(Direct)
View
2022-07-12
Purchase
2022-07-13
10:13 am
Merus N.V.MRUSLundberg Sven Ante
President, CEO & PFO
4,340$22.97$99,68519,340
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-05-23
Option Award
2024-05-28
4:10 pm
N/A
2034-05-22
Vor Biopharma Inc.VORLundberg Sven Ante
Director
30,000$030,000
(Direct)
View
2024-05-07
Option Award
2024-05-09
4:30 pm
N/A
2034-01-31
Merus N.V.MRUSLundberg Sven Ante
President, CEO & PEO
360,000$0360,000
(Direct)
View
2024-03-25
Option Award
2024-03-27
5:25 pm
N/A
2034-03-24
Q32 Bio Inc.QTTBLundberg Sven Ante
Director
12,767$012,767
(Direct)
View

Ownership
2024-03-27
5:14 pm
N/A
N/A
Q32 Bio Inc.QTTBLundberg Sven Ante
Director
0$012,331
(Direct)
View
2023-05-26
Option Award
2023-06-02
4:34 pm
N/A
2033-05-25
Vor Biopharma Inc.VORLundberg Sven Ante
Director
30,000$030,000
(Direct)
View
2023-02-02
Option Award
2023-02-03
4:23 pm
N/A
2033-02-02
Merus N.V.MRUSLundberg Sven Ante
President, CEO & PFO
380,000$0380,000
(Direct)
View
2022-06-14
Option Award
2022-06-16
5:07 pm
N/A
2032-06-13
Vor Biopharma Inc.VORLundberg Sven Ante
Director
16,911$016,911
(Direct)
View
2022-01-31
Option Award
2022-02-02
2:02 pm
N/A
2032-01-31
Merus N.V.MRUSLundberg Sven Ante
President, CEO & PFO
295,000$0295,000
(Direct)
View
2021-08-02
Exercise
2021-08-04
3:56 pm
N/A
2030-01-03
Merus N.V.MRUSLundberg Sven Ante
President, CEO & PFO
12,627$13.52357,917
(Direct)
View
2021-08-02
Exercise
2021-08-04
3:56 pm
N/A
2029-03-19
Merus N.V.MRUSLundberg Sven Ante
President, CEO & PFO
2,373$12.54357,917
(Direct)
View
2021-03-25
Gift
2021-03-29
7:18 pm
N/A
N/A
Merus N.V.MRUSLundberg Sven Ante
President, CEO & PFO
74,000$0111,495
(Direct)
View
2021-03-01
Exercise
2021-03-03
4:00 pm
N/A
2029-03-19
Merus N.V.MRUSLundberg Sven Ante
President, CEO & PFO
74,000$0431,917
(Direct)
View
2021-03-01
Exercise
2021-03-03
4:00 pm
N/A
N/A
Merus N.V.MRUSLundberg Sven Ante
President, CEO & PFO
63,170$13.52431,917
(Direct)
View
2021-03-01
Exercise
2021-03-03
4:00 pm
N/A
N/A
Merus N.V.MRUSLundberg Sven Ante
President, CEO & PFO
10,830$12.54431,917
(Direct)
View
2021-02-16
Option Award
2021-02-18
4:00 pm
N/A
2031-02-16
Merus N.V.MRUSLundberg Sven Ante
President, CEO & PFO
368,000$0368,000
(Direct)
View
2021-02-05
Option Award
2021-02-09
5:14 pm
N/A
2031-02-04
Vor Biopharma Inc.VORLundberg Sven Ante
Director
16,900$016,900
(Direct)
View

Ownership
2021-02-04
9:48 pm
N/A
N/A
Vor Biopharma Inc.VORLundberg Sven Ante
Director
0$050,394
(Direct)
View
2020-01-03
Option Award
2020-01-06
5:00 pm
N/A
2030-01-03
Merus N.V.MRUSLundberg Sven Ante
President, CEO & PFO
414,917$0414,917
(Direct)
View

Ownership
2020-01-02
09:00 am
N/A
N/A
Merus N.V.MRUSLundberg Sven Ante
President, CEO & PFO
0$054,495
(Indirect)
View